Kim HR - Search Results

1

Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.

Lee JH, Kim SH, Kim HR, Min CK, Lee JJ, Shin HJ, Jo JC, Lee JY, Moon JH, Kim K. Lee JH, et al. Among authors: kim sh, kim hr, kim k. Int J Hematol. 2023 Feb;117(2):225-235. doi: 10.1007/s12185-022-03479-6. Epub 2022 Nov 11. Int J Hematol. 2023. PMID: 36369635

2

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors.

Kim HR, Kang JH, Kim SH, Kim ST, Kim I, Min YJ, Shin SH, Oh SY, Lee GW, Lee JH, Ji JH, Huh SJ, Lee S. Kim HR, et al. Among authors: kim st, kim sh, kim i. Cancers (Basel). 2022 Jul 15;14(14):3440. doi: 10.3390/cancers14143440. Cancers (Basel). 2022. PMID: 35884501 Free PMC article.

3

Single Center Experience of Autologous Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis in Korea.

Kim HR, Yoon SE, Kim D, Choi JO, Min JH, Kim BJ, Kim JS, Lee JE, Choi JY, Jeon ES, Kim SJ, Kim K. Kim HR, et al. Among authors: kim d, kim sj, kim bj, kim js, kim k. Clin Lymphoma Myeloma Leuk. 2023 Feb;23(2):97-103. doi: 10.1016/j.clml.2022.10.010. Epub 2022 Oct 22. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36464620

4

Imatinib in c-KIT-mutated metastatic solid tumors: A multicenter trial of Korean Cancer Study Group (UN18-05 Trial).

Kim HR, Lee SJ, Ahn MS, Kim JE, Kang MJ, Hong JY, Lee J, Kim ST. Kim HR, et al. Among authors: kim st, kim je. J Cancer Res Ther. 2024 Apr 1;20(3):972-978. doi: 10.4103/jcrt.jcrt_2698_22. Epub 2023 Apr 4. J Cancer Res Ther. 2024. PMID: 39023605 Free article. Clinical Trial.

5

A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.

Kim HR, Lee SJ, Park S, Jung HA, Lee SH, Jeong HS, Chung MK, Ahn MJ. Kim HR, et al. Cancer Res Treat. 2022 Jul;54(3):719-727. doi: 10.4143/crt.2021.1019. Epub 2021 Nov 1. Cancer Res Treat. 2022. PMID: 34727492 Free PMC article. Clinical Trial.

6

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers.

Kim HR, Ahn S, Jo H, Kim H, Hong J, Lee J, Lim HY, Kang WK, Kim ST. Kim HR, et al. Among authors: kim h, kim st. Front Oncol. 2021 Dec 2;11:792340. doi: 10.3389/fonc.2021.792340. eCollection 2021. Front Oncol. 2021. PMID: 34926309 Free PMC article.

7

HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer.

Kim H, Kim R, Kim HR, Jo H, Kim H, Ha SY, Park JO, Park YS, Kim ST. Kim H, et al. Among authors: kim st, kim r, kim hr. Front Oncol. 2022 Feb 14;12:834104. doi: 10.3389/fonc.2022.834104. eCollection 2022. Front Oncol. 2022. PMID: 35252005 Free PMC article.

8

A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.

Jo H, Hong J, Kim H, Kim HR, Kwon GY, Kang KA, Park SY, Kim CK, Park BK, Chung JH, Song W, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Park SH. Jo H, et al. Among authors: kim h, kim ck, kim hr. Front Oncol. 2022 Apr 28;12:874385. doi: 10.3389/fonc.2022.874385. eCollection 2022. Front Oncol. 2022. PMID: 35574412 Free PMC article.

9

Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer.

Kim H, Kim R, Jo H, Kim HR, Hong J, Ha SY, Park JO, Kim ST. Kim H, et al. Among authors: kim st, kim r, kim hr. Therap Adv Gastroenterol. 2022 Aug 16;15:17562848221117638. doi: 10.1177/17562848221117638. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35992188 Free PMC article.

10

Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non-Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI.

Kim HR, Jo H, Kim H, Hong J, Park S, Jung HA, Lee SH, Ahn JS, Ahn MJ. Kim HR, et al. Among authors: kim h. Cancer Res Treat. 2023 Jan;55(1):344-349. doi: 10.4143/crt.2021.1603. Epub 2022 Mar 26. Cancer Res Treat. 2023. PMID: 35344648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,376 results

Search Page

Filters